BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 18717707)

  • 1. Gene therapy in epilepsy.
    Riban V; Fitzsimons HL; During MJ
    Epilepsia; 2009 Jan; 50(1):24-32. PubMed ID: 18717707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropeptide Y overexpression using recombinant adeno-associated viral vectors.
    Noé F; Frasca A; Balducci C; Carli M; Sperk G; Ferraguti F; Pitkänen A; Bland R; Fitzsimons H; During M; Vezzani A
    Neurotherapeutics; 2009 Apr; 6(2):300-6. PubMed ID: 19332323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropeptide Y gene therapy decreases chronic spontaneous seizures in a rat model of temporal lobe epilepsy.
    Noè F; Pool AH; Nissinen J; Gobbi M; Bland R; Rizzi M; Balducci C; Ferraguti F; Sperk G; During MJ; Pitkänen A; Vezzani A
    Brain; 2008 Jun; 131(Pt 6):1506-15. PubMed ID: 18477594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel approaches to epilepsy treatment.
    Sørensen AT; Kokaia M
    Epilepsia; 2013 Jan; 54(1):1-10. PubMed ID: 23106744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticonvulsant and antiepileptogenic effects mediated by adeno-associated virus vector neuropeptide Y expression in the rat hippocampus.
    Richichi C; Lin EJ; Stefanin D; Colella D; Ravizza T; Grignaschi G; Veglianese P; Sperk G; During MJ; Vezzani A
    J Neurosci; 2004 Mar; 24(12):3051-9. PubMed ID: 15044544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hippocampal NPY gene transfer attenuates seizures without affecting epilepsy-induced impairment of LTP.
    Sørensen AT; Nikitidou L; Ledri M; Lin EJ; During MJ; Kanter-Schlifke I; Kokaia M
    Exp Neurol; 2009 Feb; 215(2):328-33. PubMed ID: 19038255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene therapy mediated seizure suppression in Genetic Generalised Epilepsy: Neuropeptide Y overexpression in a rat model.
    Powell KL; Fitzgerald X; Shallue C; Jovanovska V; Klugmann M; Von Jonquieres G; O'Brien TJ; Morris MJ
    Neurobiol Dis; 2018 May; 113():23-32. PubMed ID: 29414380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene therapy for epilepsy.
    Simonato M
    Epilepsy Behav; 2014 Sep; 38():125-30. PubMed ID: 24100249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current prospects and challenges for epilepsy gene therapy.
    Weinberg MS; McCown TJ
    Exp Neurol; 2013 Jun; 244():27-35. PubMed ID: 22008258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Translational approach for gene therapy in epilepsy: Model system and unilateral overexpression of neuropeptide Y and Y2 receptors.
    Ledri LN; Melin E; Christiansen SH; Gøtzsche CR; Cifra A; Woldbye DP; Kokaia M
    Neurobiol Dis; 2016 Feb; 86():52-61. PubMed ID: 26607785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene therapy in epilepsy: the focus on NPY.
    Noe' F; Nissinen J; Pitkänen A; Gobbi M; Sperk G; During M; Vezzani A
    Peptides; 2007 Feb; 28(2):377-83. PubMed ID: 17196301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seizure suppression by GDNF gene therapy in animal models of epilepsy.
    Kanter-Schlifke I; Georgievska B; Kirik D; Kokaia M
    Mol Ther; 2007 Jun; 15(6):1106-13. PubMed ID: 17387333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Invasive drug delivery.
    Blömer U; Ganser A; Scherr M
    Adv Exp Med Biol; 2002; 513():431-51. PubMed ID: 12575831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modeling correction of severe urea cycle defects in the growing murine liver using a hybrid recombinant adeno-associated virus/piggyBac transposase gene delivery system.
    Cunningham SC; Siew SM; Hallwirth CV; Bolitho C; Sasaki N; Garg G; Michael IP; Hetherington NA; Carpenter K; de Alencastro G; Nagy A; Alexander IE
    Hepatology; 2015 Aug; 62(2):417-28. PubMed ID: 26011400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Galanin gene transfer curtails generalized seizures in kindled rats without altering hippocampal synaptic plasticity.
    Kanter-Schlifke I; Toft Sørensen A; Ledri M; Kuteeva E; Hökfelt T; Kokaia M
    Neuroscience; 2007 Dec; 150(4):984-92. PubMed ID: 17988802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene therapy for Parkinson's disease using recombinant adeno-associated viral vectors.
    Muramatsu S; Tsukada H; Nakano I; Ozawa K
    Expert Opin Biol Ther; 2005 May; 5(5):663-71. PubMed ID: 15934841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The clinical potential of antiepileptic gene therapy.
    McCown TJ
    Expert Opin Biol Ther; 2004 Nov; 4(11):1771-6. PubMed ID: 15500405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Production of clinical-grade recombinant adeno-associated virus vectors.
    Snyder RO; Flotte TR
    Curr Opin Biotechnol; 2002 Oct; 13(5):418-23. PubMed ID: 12459331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimizing viral and non-viral gene transfer methods for genetic modification of porcine mesenchymal stem cells.
    Stiehler M; Duch M; Mygind T; Li H; Ulrich-Vinther M; Modin C; Baatrup A; Lind M; Pedersen FS; Bünger CE
    Adv Exp Med Biol; 2006; 585():31-48. PubMed ID: 17120775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safe and stable noninvasive focal gene delivery to the mammalian brain following focused ultrasound.
    Stavarache MA; Petersen N; Jurgens EM; Milstein ER; Rosenfeld ZB; Ballon DJ; Kaplitt MG
    J Neurosurg; 2018 Apr; 130(3):989-998. PubMed ID: 29701544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.